Mobile

A study to evaluate the safety and tolerability of ascending doses of UCART19 given as a single infusion in patients with relapsed/refractory (R/R) B-cell acute lymphoblastic leukaemia (ALL) and to de...

Update Il y a 4 ans
Reference: EUCTR2016-000296-24

A study to evaluate the safety and tolerability of ascending doses of UCART19 given as a single infusion in patients with relapsed/refractory (R/R) B-cell acute lymphoblastic leukaemia (ALL) and to determine the maximum tolerated dose (MTD)

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the safety and tolerability of several doses of UCART19 in patient with relapsed/refractory (R/R) acute lymphoblastic leukaemia (ALL) and to determine the maximum tolerated dose (MTD).

Inclusion criteria

  • Patients with relapsed or refractory CD19 positive B-cell acute lymphoblastic leukaemia (B-ALL)

Links